Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain

Completed · Phase 2

Conditions studied: Temporomandibular Disorders, Pain, Headaches

In brief

This purpose of this study is to evaluate the safety and efficacy of treatment with nasal CO2 in the treatment of pain and other symptoms related to temporomandibular disorder (TMD).

Key facts

Study ID

NCT00484029

Run by

Capnia, Inc.

People needed

100

Starts

2007-02-01

Expected to finish

2008-12-01

Last updated by the study team

2010-08-20

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Washington, Department of Oral Medicine, Box 356370, Health Sciences Building — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.